Chemical Bank Has $1.84 Million Position in Everest Re Group Ltd (RE)

Share on StockTwits

Chemical Bank reduced its holdings in Everest Re Group Ltd (NYSE:RE) by 20.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,458 shares of the insurance provider’s stock after selling 2,237 shares during the period. Chemical Bank’s holdings in Everest Re Group were worth $1,842,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Westpac Banking Corp bought a new stake in Everest Re Group in the fourth quarter valued at approximately $670,000. Oregon Public Employees Retirement Fund increased its position in shares of Everest Re Group by 1.2% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 10,405 shares of the insurance provider’s stock worth $2,266,000 after acquiring an additional 125 shares in the last quarter. Nissay Asset Management Corp Japan ADV increased its position in shares of Everest Re Group by 1.5% during the fourth quarter. Nissay Asset Management Corp Japan ADV now owns 3,711 shares of the insurance provider’s stock worth $808,000 after acquiring an additional 54 shares in the last quarter. Penserra Capital Management LLC bought a new stake in shares of Everest Re Group during the fourth quarter worth $30,000. Finally, Kays Financial Advisory Corp ADV increased its position in shares of Everest Re Group by 8.2% during the fourth quarter. Kays Financial Advisory Corp ADV now owns 6,079 shares of the insurance provider’s stock worth $1,324,000 after acquiring an additional 459 shares in the last quarter. Institutional investors and hedge funds own 99.68% of the company’s stock.

Several brokerages have recently issued reports on RE. Wells Fargo & Co lowered their price objective on shares of Everest Re Group from $235.00 to $230.00 and set a “market perform” rating for the company in a research report on Wednesday, February 13th. Zacks Investment Research raised shares of Everest Re Group from a “sell” rating to a “hold” rating in a research report on Monday, February 4th. Morgan Stanley lowered their price objective on shares of Everest Re Group from $243.00 to $232.00 and set an “equal weight” rating for the company in a research report on Thursday, January 3rd. Deutsche Bank lowered their price objective on shares of Everest Re Group from $250.00 to $247.00 and set a “buy” rating for the company in a research report on Tuesday, November 20th. Finally, Credit Suisse Group increased their price objective on shares of Everest Re Group from $239.00 to $257.00 and gave the stock a “hold” rating in a research report on Thursday, November 1st. Seven analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Everest Re Group has a consensus rating of “Hold” and a consensus price target of $252.33.

Shares of RE opened at $216.93 on Monday. Everest Re Group Ltd has a 12 month low of $201.09 and a 12 month high of $264.88. The firm has a market cap of $8.82 billion, a P/E ratio of 46.65, a price-to-earnings-growth ratio of 0.93 and a beta of 0.33. The company has a quick ratio of 0.37, a current ratio of 0.31 and a debt-to-equity ratio of 0.08.

Everest Re Group (NYSE:RE) last announced its earnings results on Monday, February 11th. The insurance provider reported ($5.89) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $6.04 by ($11.93). Everest Re Group had a return on equity of 2.33% and a net margin of 1.40%. The business had revenue of $1.97 billion for the quarter, compared to analyst estimates of $2.03 billion. As a group, equities research analysts predict that Everest Re Group Ltd will post 23.12 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Chemical Bank Has $1.84 Million Position in Everest Re Group Ltd (RE)” was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/4160901/chemical-bank-has-1-84-million-position-in-everest-re-group-ltd-re.html.

Everest Re Group Company Profile

Everest Re Group, Ltd., through its subsidiaries, provides reinsurance and insurance products. The company operates through the U.S. Reinsurance, International, Bermuda, and Insurance segments. The U.S. Reinsurance segment writes property and casualty reinsurance; and specialty lines of business, including marine, aviation, surety, and accident and health insurance through reinsurance brokers, as well as directly with ceding companies in the Unites States.

See Also: What is a Market Correction?

Institutional Ownership by Quarter for Everest Re Group (NYSE:RE)

Receive News & Ratings for Everest Re Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everest Re Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Cipher Capital LP Buys New Holdings in Fortune Brands Home & Security Inc
Cipher Capital LP Buys New Holdings in Fortune Brands Home & Security Inc
Nektar Therapeutics  Shares Sold by Gotham Asset Management LLC
Nektar Therapeutics Shares Sold by Gotham Asset Management LLC
Cipher Capital LP Takes $906,000 Position in New York Times Co
Cipher Capital LP Takes $906,000 Position in New York Times Co
Cipher Capital LP Invests $821,000 in Sensata Technologies Holding PLC  Stock
Cipher Capital LP Invests $821,000 in Sensata Technologies Holding PLC Stock
Capital Financial Planning LLC Buys New Position in NEWTEK Business Services Corp
Capital Financial Planning LLC Buys New Position in NEWTEK Business Services Corp
Genuine Parts  Position Lowered by Fmr LLC
Genuine Parts Position Lowered by Fmr LLC


© 2006-2019 Ticker Report